Marché du diagnostic respiratoire en Asie-Pacifique – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse et taille du marché du diagnostic respiratoire en Asie-Pacifique

La région Asie-Pacifique est largement touchée par le fardeau des maladies chroniques, en particulier après la pandémie, qui a accru l'adoption des diagnostics respiratoires. Les maladies chroniques sont l'un des principaux problèmes de santé au monde, entraînant environ 40 millions de décès chaque année, dont 8,5 millions en Asie. Les progrès technologiques, la portabilité croissante et la facilité d'utilisation des appareils devraient accroître la croissance. L'incidence croissante des maladies respiratoires a suscité une grande préoccupation quant au diagnostic précis des maladies et a donc ouvert la voie à la croissance du marché des diagnostics respiratoires.

Data Bridge Market Research analyse le taux de croissance du marché du diagnostic respiratoire au cours de la période de prévision 2023-2030. Le TCAC attendu du marché du diagnostic respiratoire a tendance à être d'environ 9,8 % au cours de la période de prévision mentionnée. Le marché était évalué à 1 441,7 millions USD en 2022 et devrait atteindre 3 045,75 millions USD d'ici 2030. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe de recherche sur le marché Data Bridge comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée et segmentation du marché du diagnostic respiratoire en Asie-Pacifique

Market Definition

Respiratory diagnostics are the type of medical products and technologies that are widely used to diagnose the respiratory diseases and disorders in the patients. Respiratory diagnostics are effective since they can diagnose the diseases early. It involve procedures such as computed tomography, spirometry, oximetry, chest X- ray, transcutaneous carbon dioxide monitoring, sniff nasal inspiratory pressure (SNIP) among several other types.

Asia-Pacific Respiratory Diagnostics Market Dynamics

Drivers

• Increasing Rate of COPD

The increasing prevalence of COPD is driving the market growth at a fast pace. For instance, as per the study named "COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences" published in the MDPI Diagnostics in July 2021, the incidence of COPD in the Asia-Pacific countries is expected at 4.4% to 16.7% in China, 14.5% in Australia, and 5.6% in Indonesia; and COPD was 13.4% in Korea, 4.7% in Malaysia, 8.6% in Japan, 3.7% to 6.8% in Thailand, 3.5% to 20.8% in the Philippines, 5.4% to 6.1% in Taiwan, and 6.7% in Vietnam. Thus, this increasing prevalence demands increased diagnostics which boost the market growth.

• Increased Technological Advancements

The technological advances, and ease of operation of devices are expected to boost the segment growth. For Instance, Vyaire Medical launched the AioCare mobile spirometry system in more than 15 countries which includes Australia and other countries in 2021. This clinically proven technology increases upon Vyaire’s deep respiratory diagnostics expertise and enables physicians to diagnose pulmonary diseases as accurately as hospital-grade spirometers. It also performs high-quality patient monitoring through advanced digital connectivity at home. Thus, this factor boosts the market growth.

Opportunities

• Increased Rate of Tuberculosis

The increasing rate of tuberculosis in the Asia-Pacific region is boosting the growth of the market. The rate of TB disease among Asian persons is 14.4 cases per 100,000 persons. In 2021, eight countries of Asia resulted for more than two-thirds of global TB cases which are India (28%), Indonesia (9.2%), China (7.4%), the Philippines (7.0%), Pakistan (5.8%), Nigeria (4.4%), Bangladesh (3.6%) and Democratic Republic of the Congo (2.9%). Thus, all these factors boost the market growth.

• Growing Product Launches and Collaborations

Numerous product launches, partnership and agreement are initiated by many companies globally, which are also increasing the respiratory diagnostics market. For instance, Cipla Limited launched Spirofy which is India's first pneumotach-based portable, wireless Spirometer, on World COPD Day in November 2021. Thus, these kinds of launches associated with the respiratory diagnostics boost the market growth.

Restraints/Challenges

• High Cost of Diagnostic Instruments

The increased expenditure required for the installation of these instruments hamper the market growth. Many of the diagnostic equipment are very high in cost, becoming unaffordable for many underdeveloped countries. Numerous market players make huge investments in installing new and advanced machines to increase the process and in return the cost is increased. Thus, this factor hamper the market growth.

This respiratory diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the respiratory diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2022, Max Ventilator launched multifunctional non-invasive (NIV) ventilators in India. This ventilator comes with inbuilt oxygen therapy and humidifier. This device is launched keeping in mind the feasibility of the end-users. It is lightweight (around 5 kgs), the device is extremely portable and handy as it comes with a trolley.

Asia-Pacific Respiratory Diagnostics Market Scope

The respiratory diagnostics market is segmented on the basis of product and services, test type, diseases, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

• Instruments and Devices
• Assays and Reagents
• Services and Software

Test Type

• Traditional Diagnostic Tests
• Mechanical Tests
• Imaging Tests
• Molecular Diagnostic Tests

Diseases

• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Cancer
• Asthma
• Tuberculosis
• Bronchitis
• Pulmonary Fibrosis
• Other Diseases

End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

 Asia-Pacific Respiratory Diagnostics Market Regional Analysis/Insights

The respiratory diagnostics market is analyzed and market size insights and trends are provided by product and services, test type, diseases, end-user and distribution channel as referenced above.

The major countries covered in the respiratory diagnostics market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China is leading the market growth because of the growing focus on the high incidence of the disorders among old elderly population. The increasing social media concerns are also acting as major growth factors for the market. Moreover, several companies are advancing their diagnosis products by using new techniques to obtain target-specific and accurate results which is boosting the growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The respiratory diagnostics also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for respiratory diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the respiratory diagnostics market. The data is available for historic period 2011-2021.

Competitive Landscape and Asia-Pacific Respiratory Diagnostics Market Share Analysis

The respiratory diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to respiratory diagnostics market.

Key players operating in the respiratory diagnostics market include:

• BD (U.S.)
• COSMED srl (Italy)
• Abbott (U.S.)
• NIHON KOHDEN CORPORATION (Japan)
• Drägerwerk AG & Co. KGaA (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• General Electric (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Medtronic (Ireland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• MGC Diagnostics Corporation (U.S.)
• Masimo (U.S.)
• BIOMÉRIEUX (France)
• Carestream Health  (U.S.)
• VYAIRE (U.S.)
• Seegene Inc. (South Korea)
• ResMed (U.S.)

SKU-57095